MATHEW J BRAKORA
Allopathic & Osteopathic Physicians|Hospitalist MUSKEGON, MI NPI 1013989177
Browse related groups: Allopathic & Osteopathic Physicians|Hospitalist MI Novo Nordisk AS All categories
General Payments — all program years on this page
$2,949.72
- Category: General Payments
- Program years: PY2018–2024
- Record count: 86
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $296.58 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.58 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $201.59 | 2 |
| E.R. Squibb & Sons, L.L.C. | $40.08 | 2 |
| Merck Sharp & Dohme Corporation | $29.61 | 2 |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.30 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097253826 | Novo Nordisk Inc | $100.79 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097345506 | Novo Nordisk Inc | $100.80 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101228179 | E.R. Squibb & Sons, L.L.C. | $20.68 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101228207 | E.R. Squibb & Sons, L.L.C. | $19.40 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105916612 | VERTEX PHARMACEUTICALS INCORPORATED | $25.30 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141666164 | Merck Sharp & Dohme LLC | $14.71 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141858714 | Merck Sharp & Dohme LLC | $14.90 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.